Robeco Institutional Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $147M | Buy |
|
|||||
2025
Q1 | $70.8M | Sell |
|
|||||
2024
Q4 | $115M | Sell |
|
|||||
2024
Q3 | $138M | Sell |
|
|||||
2024
Q2 | $174M | Sell |
|
|||||
2024
Q1 | $194M | Buy |
|
|||||
2023
Q4 | $186M | Buy |
|
|||||
2023
Q3 | $151M | Buy |
|
|||||
2023
Q2 | $143M | Sell |
|
|||||
2023
Q1 | $141M | Sell |
|
|||||
2022
Q4 | $136M | Buy |
|
|||||
2022
Q3 | $98.2M | Buy |
|
|||||
2022
Q2 | $71.6M | Buy |
|
|||||
2022
Q1 | $61.8M | Buy |
|
|||||
2021
Q4 | $43.6M | Sell |
|
|||||
2021
Q3 | $36.8M | Sell |
|
|||||
2021
Q2 | $41M | Buy |
|
|||||
2021
Q1 | $37.9M | Sell |
|
|||||
2020
Q4 | $68.2M | Sell |
|
|||||
2020
Q3 | $96.8M | Buy |
|
|||||
2020
Q2 | $89.5M | Buy |
|
|||||
2020
Q1 | $19M | Buy |
|
|||||
2019
Q4 | $7.15M | Buy |
|
|||||
2019
Q3 | $4.86M | Sell |
|
|||||
2019
Q2 | $6.91M | Sell |
|
|||||
2019
Q1 | $7.54M | Buy |
|
|||||
2018
Q4 | $4.18M | Sell |
|
|||||
2018
Q3 | $7.17M | Buy |
|
|||||
2018
Q2 | $5.88M | Sell |
|
|||||
2018
Q1 | $5.97M | Buy |
|
|||||
2017
Q4 | $4M | Buy |
|
|||||
2017
Q3 | $2.38M | Buy |
|
|||||
2017
Q2 | $2.01M | Buy |
|
|||||
2017
Q1 | $105K | Hold |
|
|||||
2016
Q4 | $71K | Hold |
|
|||||
2016
Q3 | $84K | Sell |
|
|||||
2016
Q2 | $923K | Hold |
|
|||||
2016
Q1 | $853K | Hold |
|
|||||
2015
Q4 | $1.35M | Buy |
|
|||||
2015
Q3 | $846K | Hold |
|
|||||
2015
Q2 | $1M | Buy |
|
|||||
2015
Q1 | $55K | Sell |
|
|||||
2014
Q4 | $794K | Buy |
|
|||||
2014
Q3 | $460K | Buy |
|
|||||
2014
Q2 | $319K | Buy |
|
|||||
2014
Q1 | $131K | Buy |
|
|||||
2013
Q4 | $97K | Hold |
|
|||||
2013
Q3 | $99K | Hold |
|
|||||
2013
Q2 | $104K | Buy |
|